#Lupus in the News: The Phase III trials of self-administered #Saphnelo (anifrolumab by AstraZeneca) showed significant reduction in disease activity for patients with lupus – who are also on standard #medications as well.
Link to announcement: ow.ly/gyV050X3obz
SC #Saphnelo meets its primary endpoint. How exciting for patients who find IV infusions too time consuming and difficult! I hope it is approved and available for my patients quickly!
www.astrazeneca-us.com/media/press-...
A photo of me, my head is in the bottom left corner of the photo. I am sitting in a blue medical recliner. My pink hair is slicked back into a ponytail I am wearing my glasses, cateye shaped and green glitter rims. I am wearing a mask. Behind me is a window open to a hillside of forest landscape. And to my right is a tall IV bag stand with a bag of my medication.
Been a while... it's #infusionday!
Got about another 30 mins here to finish out my #saphnelo treatment. Keeps the #lupus in check.
Infusion #3 at new infusion center. Took almestica am hour to get started. hopefully it doesn't always take this long. Follow-up with my doctor is on Monday so we will see if we will continue.
#midwesterngirlonthebelt #saphnelo #lupuswarrior #lupusawareness #ivegotthis #lupus
